by OmegaQuant | Aug 13, 2020 | Uncategorized
Mental illness is highly prevalent in the US. In fact, millions of people are affected each year by some form of mental illness, with 1 in every 5 adults developing some type of mental issue. That’s around 44 million individuals. About 18% of adults in America have...
by OmegaQuant | Mar 11, 2020 | Heart Health, Omega-3 Index, Omega-3s, Research, Uncategorized
Headlines continue to swing back and forth on the value of fish oil supplements for heart health. But we at OmegaQuant firmly believe in their ability to deliver health protective amounts of the omega-3 fatty acids EPA and DHA, especially when it comes to raising the...
by OmegaQuant | Mar 6, 2019 | Heart Health, Prenatal DHA, Uncategorized
Omega-3 intake is generally low among people in most developed countries, and pregnant women are no exception. For this group, taking the omega-3 DHA during pregnancy is particularly important. And now, there is new research that adds to the growing list of DHA’s...
by OmegaQuant | Nov 13, 2018 | Uncategorized
This past Saturday, November 10th, two pivotal studies on omega-3s — REDUCE-IT and VITAL — were presented at the American Heart Association meeting. The results of these studies demonstrated unequivocally why you need to take omega-3s. In a Washington Post article,...
by Kristina Jackson | Aug 10, 2016 | Omega-3 Index, Research, Uncategorized
After someone has had a heart attack, some of their heart tissue has been damaged or is dead (“myocardial infarct”). The ability for the heart to “remodel” itself in order to compensate for the dead tissue or even revive said tissue is imperative for the heart to be...
These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.
